UBS, Faces

UBS Faces Mounting Regulatory Scrutiny as Switzerland Charts Independent Course

24.03.2026 - 04:36:44 | boerse-global.de

Swiss regulator FINMA plans major capital hike for UBS, diverging from US & UK deregulation. New rules follow Credit Suisse collapse, with key decisions expected in April.

UBS Faces Mounting Regulatory Scrutiny as Switzerland Charts Independent Course - Foto: über boerse-global.de

While financial regulators in other major economies move to ease capital requirements for their banking sectors, Switzerland is heading in the opposite direction. The Swiss Financial Market Supervisory Authority (FINMA) is poised to significantly tighten the rules for UBS, creating a competitive landscape that presents one of the most substantial regulatory tests in the bank's history.

A Divergent Regulatory Path

The international contrast is striking. In the United States, capital requirements are set to decrease by 168 basis points to 9.8 percent as part of broader deregulation efforts. Similarly, the United Kingdom plans a reduction of 102 basis points to 11.3 percent. For UBS, however, the outlook is markedly different. Analysts at Alvarez & Marsal project that the minimum Common Equity Tier 1 (CET1) capital ratio for the bank could be raised by a substantial 769 basis points, reaching 19.2 percent.

This Swiss stance is a direct response to the collapse of Credit Suisse in 2023 and its subsequent government-orchestrated acquisition by UBS. As the country's sole globally systemically important bank, UBS now bears the full weight of the lessons learned from that crisis. A key component of the new framework will require the bank to fully back its holdings in foreign subsidiaries with equity capital, with these heightened requirements being phased in over a seven-year period.

Should investors sell immediately? Or is it worth buying UBS?

Board Renewal and a Pivotal Spring

From an operational perspective, UBS's business remains robust. The bank reported a net profit of $7.8 billion for 2025 and has completed the migration of former Credit Suisse clients. Given that the new capital regulations are not expected to take effect before 2027, UBS is maintaining its target of achieving a return on CET1 capital (RoCET1) of approximately 15 percent by the end of 2026.

The coming weeks are critical for clarifying the future regulatory environment. The Swiss Federal Council could enact a corresponding ordinance by mid-April. Concurrently, UBS will hold its Annual General Meeting in Basel on April 15. This gathering will see a significant refresh of the board, with three long-serving directors, including Vice Chairman Lukas Gähwiler, not standing for re-election.

Their nominated successors bring deep expertise in regulation and financial stewardship: Agustín Carstens, former General Manager of the Bank for International Settlements; Luca Maestri, former CFO of Apple; and Markus Ronner. The appointment of such a trio is particularly timely given the current regulatory focus.

Market sentiment reflects the prevailing uncertainty. UBS shares are currently trading about 20 percent below their January peak for the year. The contours of the future capital framework will become clearer following the Federal Council's decision in April and the subsequent legislative proposal expected in the first half of 2026. These developments will ultimately define how much flexibility UBS retains for shareholder returns and strategic growth initiatives.

Ad

UBS Stock: New Analysis - 24 March

Fresh UBS information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated UBS analysis...

So schätzen die Börsenprofis UBS Aktien ein!

<b>So schätzen die Börsenprofis UBS Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
CH0244767585 | UBS | boerse | 68971356 |